EA200000419A1 - Применение тиазолидиндионов для лечения гипергликемии - Google Patents

Применение тиазолидиндионов для лечения гипергликемии

Info

Publication number
EA200000419A1
EA200000419A1 EA200000419A EA200000419A EA200000419A1 EA 200000419 A1 EA200000419 A1 EA 200000419A1 EA 200000419 A EA200000419 A EA 200000419A EA 200000419 A EA200000419 A EA 200000419A EA 200000419 A1 EA200000419 A1 EA 200000419A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hyperglycemia
application
thiazolidindion
treatment
mammal
Prior art date
Application number
EA200000419A
Other languages
English (en)
Other versions
EA002659B1 (ru
Inventor
Робин Эдвин Бакингэм
Стефен Элистэр Смит
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000419A1 publication Critical patent/EA200000419A1/ru
Publication of EA002659B1 publication Critical patent/EA002659B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Описывается способ лечения гипергликемии, при которой уровни глюкозы в плазме находятся в пределах от повышенных нормальных до ≤126 мг/дл; указанный способ включает введение эффективного нетоксичного и фармацевтически приемлемого количества инсулинового сенсибилизатора млекопитающему, которое в этом нуждается.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000419A 1997-10-13 1998-10-12 Применение 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона для лечения гипергликемии EA002659B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (2)

Publication Number Publication Date
EA200000419A1 true EA200000419A1 (ru) 2000-10-30
EA002659B1 EA002659B1 (ru) 2002-08-29

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000419A EA002659B1 (ru) 1997-10-13 1998-10-12 Применение 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона для лечения гипергликемии

Country Status (24)

Country Link
EP (1) EP1023056A1 (ru)
JP (1) JP2001519382A (ru)
KR (1) KR20010024481A (ru)
CN (1) CN1281359A (ru)
AP (1) AP2000001787A0 (ru)
AU (1) AU9547098A (ru)
BG (1) BG104404A (ru)
BR (1) BR9815219A (ru)
CA (1) CA2306086A1 (ru)
CZ (1) CZ20001297A3 (ru)
EA (1) EA002659B1 (ru)
GB (1) GB9721693D0 (ru)
HR (1) HRP20000255A2 (ru)
HU (1) HUP0003922A3 (ru)
ID (1) ID24521A (ru)
IL (1) IL135513A0 (ru)
NO (1) NO20001898L (ru)
NZ (1) NZ503862A (ru)
OA (1) OA11683A (ru)
PL (1) PL339813A1 (ru)
SK (1) SK5312000A3 (ru)
TR (1) TR200000958T2 (ru)
WO (1) WO1999018943A1 (ru)
YU (1) YU28800A (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137915T3 (es) * 1987-09-04 2000-01-01 Beecham Group Plc Derivados de tiazolidindiona sustituida.
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
OA11683A (en) 2005-01-12
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
PL339813A1 (en) 2001-01-02
HUP0003922A3 (en) 2001-12-28
JP2001519382A (ja) 2001-10-23
HUP0003922A2 (hu) 2001-10-28
AU9547098A (en) 1999-05-03
IL135513A0 (en) 2001-05-20
TR200000958T2 (tr) 2000-08-21
CA2306086A1 (en) 1999-04-22
ID24521A (id) 2000-07-20
NO20001898L (no) 2000-06-09
CN1281359A (zh) 2001-01-24
BG104404A (bg) 2000-12-29
YU28800A (sh) 2003-02-28
EA002659B1 (ru) 2002-08-29
KR20010024481A (ko) 2001-03-26
NO20001898D0 (no) 2000-04-12
EP1023056A1 (en) 2000-08-02
BR9815219A (pt) 2001-01-02
NZ503862A (en) 2003-01-31
HRP20000255A2 (en) 2001-02-28
SK5312000A3 (en) 2000-09-12
WO1999018943A1 (en) 1999-04-22
CZ20001297A3 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
EA199900168A1 (ru) Применение glp-1 или его аналогов в лечении инфаркта миокарда
EA200101089A1 (ru) Новый способ лечения
EA200100002A1 (ru) Бензотиепины, обладающие активностью ингибиторов перемещения желчных кислот в подвздошной кишке и поглощения таурхолата
EA200001044A2 (ru) Соединения для лечения женской сексуальной дисфункции
EA199800316A1 (ru) СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ
EA200000748A1 (ru) Способ введения мономерных аналогов инсулина
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
BR9909382A (pt) Anticorpo humanizado contra o fator tissular humano (tf) e processo de produção de anticorpo humanizado
DE69940975D1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
CY1105254T1 (el) Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο
AU6178198A (en) Method of treating a tumor
ES2166001T3 (es) Utilizacion de compuestos antimineralcorticoides contra el sindrome de abstinencia de narcoticos.
CY1107745T1 (el) Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια
EA200000042A1 (ru) Способ лечения диабета росиглитазоном и инсулином
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
EA199800866A1 (ru) Способ снятия боли
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
EA200000419A1 (ru) Применение тиазолидиндионов для лечения гипергликемии
EA200000418A1 (ru) Применение тиазолидиндионов для лечения гипергликемии
BR9810186A (pt) Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade
BR9810292A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase
EA200000039A1 (ru) Лечение диабета тиазолидиндионом и сульфонилмочевиной
BR9915214A (pt) Combinações contendo um beta-agonista e umagente anti-diabético adicional
EA199800819A1 (ru) Способ лечения биполярного расстройства
EA199900006A1 (ru) Препарат и способ для лечения застоной сердечной недостаточности

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU